Isolation of Enterobacter intermedium from the gallbladder of a patient with cholecystitis.
We describe the isolation and identification of Enterobacter intermedium from the gallbladder of a patient with cholecystitis. There have been only four documented isolations of this organism from humans; it normally occurs in surface water and unpolluted soils. The identification was initially made by a MicroScan Walk/Away system with a Neg Combo 18 conventional identification-susceptibility panel. The organism is susceptible to the aminoglycosides and imipenem but resistant to the cephalosporins and ciprofloxacin.
O'Hara
C M
CM
Centers for Disease Control and Prevention, Atlanta, Georgia, USA. cmol@cdc.gov
Steward
C D
CD
Wright
J L
JL
Tenover
F C
FC
Miller
J M
JM
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002763:Cholecystectomy; D002764:Cholecystitis / Q000175:diagnosis / Q000382:microbiology* / Q000601:surgery; D004754:Enterobacter / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification*; D005704:Gallbladder / Q000382:microbiology*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged
D000900:Anti-Bacterial Agents